Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-05

Clinical Trial Update: Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating acetazolamide for obstructive sleep apnea, focusing on patient-centered and neurocognitive outcomes, and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • acetazolamide (Diamox) (acetazolamide)

Snippet

Sponsor: University of California, San Diego | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: RECRUITING